CXApp Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CXApp Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.58M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $7.14M | Mar 30, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $888.0K | Mar 30, 2026 |
| FY2025 | Sep 30, 2025 | $991.0K | Mar 30, 2026 |
| FY2025 | Jun 30, 2025 | $1.05M | Mar 30, 2026 |
| FY2025 | Mar 31, 2025 | $1.07M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.43M | Mar 30, 2026 |
| FY2025 | Sep 30, 2024 | $1.53M | Mar 30, 2026 |
| FY2025 | Jun 30, 2024 | $1.41M | Mar 30, 2026 |
| FY2025 | Mar 31, 2024 | $1.49M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.62M | Apr 7, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.47M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($19.41M) | Mar 30, 2026 |
| FY2022 | Dec 31, 2022 | $8.35M | Apr 21, 2023 |
| FY2022 | Sep 30, 2022 | $9.52M | Apr 21, 2023 |
| FY2022 | Jun 30, 2022 | $783.4K | Apr 21, 2023 |
| FY2022 | Dec 31, 2021 | $9.21M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($4.08M) | Mar 30, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.58M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($13.74M) | Mar 30, 2026 |
| FY2022 | Dec 31, 2022 | ($2.95M) | Apr 21, 2023 |
| FY2022 | Dec 31, 2021 | ($1.50M) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($252.8K) | Mar 30, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.64M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $6.38M | Mar 30, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.38M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($7.33M) | Mar 30, 2026 |
| FY2022 | Dec 31, 2022 | ($761.1K) | Apr 21, 2023 |
| FY2022 | Dec 31, 2021 | ($595.3K) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($514.7K) | Mar 30, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.0K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $30.0K | Mar 30, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.43M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $31.80M | Mar 30, 2026 |
| FY2023 | Dec 31, 2023 | $36.58M | May 24, 2024 |
| FY2023 | Dec 31, 2022 | $33.43M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | $279.37M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $280.24M | Mar 30, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.45M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $16.21M | Mar 30, 2026 |
| FY2023 | Dec 31, 2023 | $11.18M | May 24, 2024 |
| FY2023 | Dec 31, 2022 | $9.84M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | $21.70M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $31.79M | Mar 30, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.98M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $15.59M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $25.40M | Mar 30, 2026 |
| FY2023 | Dec 31, 2022 | $23.59M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | ($21.09M) | Apr 21, 2023 |
| FY2022 | Dec 31, 2020 | ($30.30M) | Apr 21, 2023 |
| FY2021 | Jul 19, 2020 | $0 | Mar 30, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.59M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $8.74M | Mar 30, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($90.68M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($77.21M) | Mar 30, 2026 |
| FY2022 | Dec 31, 2022 | ($3.72M) | Apr 21, 2023 |
| FY2022 | Dec 31, 2021 | ($21.09M) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($30.30M) | Mar 30, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.10M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.88M | Mar 30, 2026 |
| FY2022 | Dec 31, 2022 | $224.5K | Apr 21, 2023 |
| FY2021 | Dec 31, 2021 | $406.1K | Mar 30, 2022 |